The global biotherapeutics virus removal filters market is expected to grow at a strong Compound Annual Growth Rate (CAGR) of 8.0% to reach US$ 972.6 million by 2033. This substantial increase from a value of US$ 451.2 million in 2023 highlights the growing need in the biopharmaceutical manufacturing industry for trustworthy virus elimination solutions.
Preview Next-Level Insights Sample :
https://www.futuremarketinsights.com/reports/sample/rep-gb-6054
The effectiveness and safety of biopharmaceutical medications are greatly dependent on biotherapeutics virus elimination filters. By trapping viruses bigger than the filter’s pore size, these filters successfully shield patients from possible viral contamination through the application of a size-exclusion mechanism.
Key Factors Driving Market Growth:
- Rising Demand for Biotherapeutics: The growing adoption of biotherapeutic drugs for treating various diseases is fueling the demand for virus removal filters during the manufacturing process.
- Strict Regulatory Requirements: Stringent regulations by global health agencies mandate robust virus removal processes, leading to increased adoption of these filters.
- Technological Advancements: Continuous advancements in filtration technology are leading to the development of more efficient and reliable virus removal filters.
- Mitigating Contamination Risks: The ever-present risk of viral contamination in biotherapeutics necessitates the use of these filters, ensuring patient safety.
Competitive Landscape:
Some of the key participants present in the global biotherapeutics virus removal filters market includes Pall Corporation, Z-Medica, LLC, Asahi Kasei Corporation, Merck KGaA, and Sartorius AG among others.
Attributed to the presence of such a high number of participants, the market is highly competitive. While global players such as Pall Corporation, Z-Medica, LLC, and Asahi Kasei Corporation account for a considerable market size, several regional-level players are also operating across key growth regions, particularly in the Asia Pacific.
- In April 2022- Merck, announced an advancement in its bioprocessing portfolio with the acquisition of the MAST® The acquisition of the MAST® platform adds fully automated sampling to the bioprocessing portfolio.
- In December 2021- Asahi Kasei Medical Co., Ltd. announced the acquisition of Bionique Testing Laboratories LLC (Bionique).
Key Players in the Global Market:
- Pall Corporation
- Z-Medica LLC
- Asahi Kasei Corporation
- Merck KGaA
- Sartorius AG
Our Methodology Overview:
https://www.futuremarketinsights.com/request-report-methodology/rep-gb-6054
Biotherapeutics Virus Removal Filters Market Segmentation:
By Technology:
- Size Exclusion Technology
- Depth Filtration Technology
By Application:
- Monoclonal Antibodies
- Blood & Plasma
- Enzymes
- Proteins
By End-user:
- Biopharmaceutical Companies
- Clinical Research Organizations
- Academic Institutions
- Others
By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East & Africa (MEA)
In-Depth Market Analysis: Purchase Now to Access:
https://www.futuremarketinsights.com/checkout/6054
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube